shutterstock-135807482-roche-1
lucarista / shutterstock.com
13 July 2021MedtechAlex Baldwin

English court says Roche did not infringe insulin pump patents

The  English High Court has cleared  Roche of patent infringement claims over its line of insulin pumps but shot down the pharma giant’s attempt to invalidate the plaintiff’s patent.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
4 April 2022   Roche’s subsidiary Genentech has asked a Delaware court to block two of Novartis’ units from selling a generic version of the blockbuster lung-disease drug Esbriet.
Big Pharma
19 May 2022   Roche subsidiary Spark Therapeutics has settled a lawsuit with rival gene-therapy company Bluebird Bio, which it had accused of infringing its “Spark” trademarks when marketing treatment for sickle-cell disease.
Americas
12 July 2022   The dispute over a patent covering a blood glucose level monitor ends with a multimillion-dollar payment and a licence agreement.

More on this story

Big Pharma
4 April 2022   Roche’s subsidiary Genentech has asked a Delaware court to block two of Novartis’ units from selling a generic version of the blockbuster lung-disease drug Esbriet.
Americas
12 July 2022   The dispute over a patent covering a blood glucose level monitor ends with a multimillion-dollar payment and a licence agreement.
Big Pharma
19 May 2022   Roche subsidiary Spark Therapeutics has settled a lawsuit with rival gene-therapy company Bluebird Bio, which it had accused of infringing its “Spark” trademarks when marketing treatment for sickle-cell disease.

More on this story

Big Pharma
4 April 2022   Roche’s subsidiary Genentech has asked a Delaware court to block two of Novartis’ units from selling a generic version of the blockbuster lung-disease drug Esbriet.
Americas
12 July 2022   The dispute over a patent covering a blood glucose level monitor ends with a multimillion-dollar payment and a licence agreement.
Big Pharma
19 May 2022   Roche subsidiary Spark Therapeutics has settled a lawsuit with rival gene-therapy company Bluebird Bio, which it had accused of infringing its “Spark” trademarks when marketing treatment for sickle-cell disease.